Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07212595) titled 'Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy' on Sept. 28.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Stuart Goldstein, MD
Condition:
Acute Kidney Injury
Mechanical Ventilation
Intervention:
Drug: Amino Acid infusion
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: November 2025
Target Sample Size: 30
Countries of Recruitment:
United States
To know more, visit...